Obesity has become a widespread global health problem. In China, with the improvement of living standards, the proportion of obesity is increasing year by year. According to China’s nutrition and health status survey report, more than 280 million people are overweight and obese. And with the rise in the severity of obesity, the incidence of diabetes, hypertension, hyperlipidemia, coronary heart disease, myocardial infarction, stroke, amenorrhea, breast cancer, etc. has increased significantly, and the mortality rate has increased significantly. It is recognized by the World Health Organization as the fifth most important risk factor affecting human health. Currently, the treatment of metabolic diseases such as obesity and type 2 diabetes includes both non-surgical treatment and surgery. However, non-surgical treatments such as diet control, physical exercise, lifestyle changes, and medications are difficult to achieve long-term effectiveness or even a cure. Weight loss from a low-calorie diet will generally rebound within a short period of time; exercise with diet control can theoretically achieve lasting weight loss, but it is often difficult for patients to adhere to it for a long time; lifestyle changes are not effective in the long term; medication is even less effective for severe obesity. Once diabetes is diagnosed, we can see the arrival of serious complications 20 years later. Existing clinical practice shows that surgery is the only long-term effective modality for obese patients. Moreover, the majority of obese patients with complications such as diabetes, hyperlipidemia, hypertension, and amenorrhea are in complete or partial remission after surgery. It is the ability to not only lose weight, but also to effectively manage metabolic conditions such as type 2 diabetes that led to this procedure being named the best medical innovation of 2013 by the Cleveland Medical Center. We will judge whether the procedure is necessary based on the patient’s body mass index (BMI = weight (kg)/height2(m)). The presence of one or more obesity-related diseases such as diabetes, hypertension, hyperlipidemia, polycystic ovary syndrome and waist size (>85cm for women and >95cm for men) are also indicators for our evaluation. And we must also exclude the presence of secondary obesity due to medications, endocrine disorders, and other causes, as well as serious psycho-behavioral disorders. Unlike the original concept of treating diabetes, our procedure involves a certain degree of reduction in the stomach (the procedure is simpler and less invasive than radical gastric cancer surgery), which affects your appetite and food intake, bringing about changes in gastrointestinal hormones, flora and dynamics, producing weight loss and remission of metabolic diseases such as diabetes. The exact mechanism is being researched worldwide and by us. We will perform weight loss surgery using minimally invasive laparoscopic techniques, thus reducing your surgical trauma, post-operative pain and hospital stay, and faster post-operative recovery. We have nearly a decade of experience in laparoscopic radical gastrointestinal tumor surgery to ensure safe and minimally invasive surgery from a technical standpoint. Since 2009, we have been forming a bariatric and metabolic surgery team to carry out the corresponding clinical and research work. Now, a bariatric and metabolic surgery team consisting of minimally invasive surgery, anesthesiology, nutrition, sports rehabilitation, critical care medicine, sleep monitoring, endocrinology, cardiovascular, respiratory, gastroenterology, psychological medicine, orthopedics, masculinity and professional nursing team will be at your service to escort your weight loss journey.